phase 2_initiation
saveShanxi Ruifulai Pharmaceutical Co Ltd — brexpiprazole (Phase II Trial Initiation)
community read0 votes
Therapy area: Central Nervous System. Indication: Schizophrenia
Data sources
globaldata
Found something off?
drug timeline · 6
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalJan 31, 2023 · 1340d ago
comments(0)
5-min edit window · permanent after that